Clinical Trial Update: A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing tenofovir disoproxil fumarate (Viread) with adefovir dipivoxil in HBeAg-negative chronic hepatitis B has completed, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepsera (adefovir dipivoxil)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2010-05-19